ERBB2 and invasive ductal breast carcinoma: The study by Cen et al. analyzed 485 patients with infiltrating ductal carcinoma, highlighting that BI-RADS 3–5 microcalcifications, particularly those larger than 0.5 mm and extending beyond 2 cm, were significantly associated with the HER2-positive subtype.